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Androgens and  their nuclear  receptor  regulate genes 
necessary for development of the male phenotype, a 
process that  is thought to be modulated by extracellular 
androgen carrier proteins. Two of these carrier pro- 
teins,  testicular  androgen-binding  protein (ABP) and 
plasma sex hormone-binding globulin (SHBG), are en- 
coded  by the same gene, but differ in glycosylation and 
possibly amino acid sequence. To investigate ABP- 
SHBG gene expression in fetal rat liver, we analyzed 
RNA transcripts  and expressed protein. These studies 
demonstrated a transient expression of ABP in hepa- 
tocytes during  the time of testosterone-dependent dif- 
ferentiation of the Wolffian duct. Analysis of cDNA 
clones derived from fetal rat liver cDNA libraries iden- 
tified two cDNAs  encoded by the ABP-SHBG gene that 
represented alternatively spliced RNAs. One cDNA 
had an alternate exon 1, suggesting the function of 
another promoter in fetal  liver.  This cDNA also lacked 
testicular exon 6 DNA, an  alteration  that implicates 
the encoded protein  in  regulatory functions. The  other 
cDNA represented a fused transcript of the ABP- 
SHBG gene (exons 1-5) and  the  histidine decarboxyl- 
ase (HDC) gene, encoding a M, 98,000 precursor pro- 
tein. The  two domains were joined at splice junctions 
of the ABP-SHBG and HDC genes, which were local- 
ized to rat chromosomes 10 and 3, respectively. Our 
results  indicate that  the joining of the  two domains was 
by a trans (donor and acceptor)-splicing mechanism. 
Data from Northern hybridization experiments sug- 
gest the fusion transcript is present  in  fetal  liver RNA. 
Polymerase  chain  reaction  experiments  with  fetal  liver 
cDNA further support  the existence of an ABP-HDC 
fusion transcript, as well as the  other  alternate mRNA. 
Moreover, a M, 93,000 immunoreactive protein  was 
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transiently expressed in fetal  liver  during  the time of 
ABP and HDC gene expression. Expression of the  fu- 
sion cDNA in COS cells yielded HDC activity  and  the 
predicted size protein (Mr = 93,000) on Western im- 
munoblots. 
Androgens and their receptor play an important role in 
male sexual differentiation and function. The trans-acting 
androgen receptor (AR’) binds the male  sex steroids, testos- 
terone and dihydrotestosterone (DHT), and regulates the 
genes necessary for male sexual differentiation and develop- 
ment (1). Androgens and  the receptor are also necessary for 
the maintenance of spermatogenesis, sperm maturation,  and 
accessory sex gland function (2). Extracellular androgen car- 
rier proteins are thought to modulate androgen action by 
binding androgens in blood and  luminal fluids of the male 
reproductive tract (3, 4). Also, these  proteins  are known to 
interact with a specific external membrane receptor (5, 6). 
Although the importance of this interaction is not known, 
evidence has recently been presented that suggests steroid 
carrier proteins may actually be hormones themselves (3). 
Androgen-binding protein  (ABP) is a testicular Sertoli cell 
secretory protein that binds testosterone  and dihydrotestos- 
terone with high affinity (7). ABP acts  as  a  carrier of andro- 
gens in  the seminiferous tubule and epididymis, but  its precise 
function is not well understood (4, 8, 9). A related blood 
steroid carrier  p otein, sex hormone-binding globulin 
(SHBG),  has almost identical physicochemical properties as 
ABP, differing in glycosylation and possibly amino acid se- 
quence (4, 10). Rat ABP and human SHBG (homodimers) 
subunits  share 69% identity of their 373-amino acid residues 
(11). In man  there is a single gene encoding both ABP and 
SHBG (12). Likewise, in rat there is one ABP-SHBG gene 
(13). SHBG is synthesized in the adult liver of some species, 
including man (10, 14, 15), monkey (16),  and  rabbit  (17),  but 
the  rat liver does not produce detectable SHBG protein or 
mRNA (18, 19). However, Gunsalus et al. (20) and Carreau 
(21) reported the presence of an immunoreactive ABP-like 
protein in the serum of developing male and female rat 
embryos, suggesting it was synthesized in the liver. In  this 
manuscript we report that  the ABP gene  is expressed tran- 
siently during rat liver development. Studies of fetal liver 
ABP RNA transcripts revealed  cDNA clones that represented 
The abbreviations used are: AR, androgen receptor; ABP, andro- 
gen-binding protein; SHBG, sex hormone-binding globulin; HDC, 
histidine decarboxylase; DHT, dihydrotestosterone; RIA, radio- 
immunoassay; ID element, brain identifier repetitive DNA element; 
PCR, polymerase chain reaction; bp, base pair(s); kb, kilobase(s). 
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alternatively processed mRNAs. One of the cDNAs repre- 
sented  a RNA transcript that was apparently formed by a 
trans-splicing mechanism. Furthermore, the characteristics of 
both  alternate  transcripts suggest that  the encoded proteins 
have functions different from testicular ABP. Henceforth, the 
fetal liver protein will  be referred to  as ABP, but  SHBG would 
be equally appropriate. 
EXPERIMENTAL PROCEDURES 
Preparation  and Screening of cDNA Libraries-Preparation of the 
oligo(dT)-primed fetal rat liver (16 days post-conception) cDNA 
library (Xgtll) has been described (22). A random-primed library was 
prepared by the same technique, except random hexamers replaced 
oligo(dT) in the synthesis of first strand cDNA. The unamplified 
libraries (3 x lo6 recombinants) were screened by in situ plaque 
hybridization on Escherichia coli  Y1088, with 32P-labeled ABP cDNA 
as previously described (23). Positive recombinants were plaque pu- 
rified, recombinant XDNA was prepared by the method of Kaslow 
(24), and  the DNA inserts were isolated by electroelution. 
Transient Expression in Monkey Kidney Cells-The  DNA inserts 
were  cloned into the expression vector pCMV or pCMV5, a modified 
pCMV plasmid containing an EcoRI cloning site (25). The pCMV 
plasmids were from David Russel and Matthew Lorence, University 
of Texas Southwestern Medical Center, Dallas. These  plasmidvectors 
contain the promoter-enhancer of the cytomegalovirus immediate 
early gene, the poly(A) addition-transcription  terminator region of 
the human growth hormone gene, the SV40 origin of replication, and 
a polylinker region  for the insertion of cDNAs. Recombinants with 
the correct orientation for expression were identified by restriction 
endonuclease analysis and  the plasmid DNA  was purified by CsC1- 
ethidium bromide centrifugation (42). For transfection, subconfluent 
COS 7 cells (lo6 cells/lOO-mm dish) were transfected with 5 pg of 
recombinant pCMV DNA/dish by the DEAE-dextran method (26). 
After 48 h the cells were suspended in phosphate-buffered saline 
(minus Ca2+ and M e )  and lysed  by three cycles of freeze (-70 "C)- 
thaw (37 "C). After centrifugation (14,000 X g for 15 min at 4  "C) the 
soluble supernatant fraction and  the pellet, suspended in  phosphate- 
buffered saline, were stored at  -20 "C. Each medium was concen- 
trated with a Centricon 10 microconcentrator (Amicon, Danvers, 
MA). The medium and cell extracts were assayed for protein (Bio- 
Rad Protein Assay with IgG as  standard), L-histidine decarboxylase 
(HDC) enzymatic activity, ABP by RIA (27), specific DHT binding 
(28), and immunoreactive ABP by Western blot analysis (see  below). 
Conditions for the HDC assay were as described (29), with [3H] 
histidine as substrate. The formation of [3H]histamine was deter- 
mined by thin layer chromatography (30). 
The 2.3-kb insert of XgtllHDC-18 DNA (22) was cloned directly 
in  the EcoRI site of pCMV5 DNA, forming pCMVHDC-18, which 
contains the insert in the proper orientation for expression. HDC-18 
DNA encodes the  total amino acid sequence of rat histidine decar- 
boxylase (22). To construct pCMVABP6, XgtllABP6 DNA (23), 
which contains the full-length ABP cDNA, was  cleaved with EcoRI 
to yield a  partial digest (ABP cDNA contains an  internal EcoRI site). 
The 1400-bp DNA fragment was purified by electroelution and cloned 
into  the EcoRI site of pSP65. The insert was  removed from pSP65 
DNA with SmaI and  PvuII  (partial),  and  the fragment was cloned in 
SmaI-cleaved pCMV  DNA in the correct orientation for expression. 
Two pCMV constructs were utilized to study the expression of clone 
FLABP-HDC. For construct pCMVFLABP-HDC the 3' 2.3-kb EcoRI 
fragment of XgtllFLABP-HDC was cleaved with HindIII, and  the 
generated 2.25-kb  EcoRI-Hind111 fragment was cloned into 
pBluescript (SK-) DNA (cleaved with EcoRI and HindIII). The 
resulting recombinant DNA  was  cleaved with EcoRI and  the 5'  720- 
bp EcoRI fragment of clone FLABP-HDC was inserted  in the same 
orientation as in FLABP-HDC. The cloned DNA, containing all of 
FLABP-HDC cDNA, except 50 bp at  the 3'-end was  cleaved  from 
recombinant pBluescript DNA with SmaI and HincII (restriction 
endonuclease sites  in the Bluescript polylinker region, but  not in the 
cDNA) and cloned into the SmaI site in pCMV DNA, yielding 
pCMVFLABP-HDC DNA. To ensure that the recombinant was 
constructed properly, the purified double-stranded DNA used for 
transformation of COS cells was sequenced directly with internal 
oligonucleotides, confirming the correct sequence at  each cloning site, 
including the internal EcoRI site. When pCMV5, containing  a EcoRI 
cloning site, became available pCMV5FLABP-HDC was constructed. 
XgtllFLABP-HDC DNA  was  cleaved with EcoRI to yield a  partial 
digest, and  the 3-kb fragment was cloned into EcoRI-cleaved pCMV5 
DNA in both orientations. In pCMV5FLABP-HDCrev DNA, the 
insert is in the opposite orientation for expression. 
Chromosomal  Localization-The production and  rat chromosomal 
contents of the  rat X mouse somatic cell hybrids have been described 
(31, 32). DNA extracted from the progenitor cells and each hybrid 
were digested with restriction endonucleases, electrophoresed on 0.7% 
agarose gels, transferred with alkali to nylon membranes (Gene- 
ScreenPlus, Du Pont-New England Nuclear) and the membranes 
were hybridized with 32P-labeled cDNA probes for rat ABP (23) or 
HDC (2.3-kb 3' EcoRI fragment of clone FLABP-HDC). The 2.3-kb 
fragment contains 17 bp of ABP cDNA but does not hybridize with 
ABP mRNA or DNA under our reaction conditions. The hybridizing 
rat DNA fragments could be easily distinguished from the mouse 
fragments of hybridization with both probes. Hybridization of HDC 
cDNA with BamHI-digested DNA  yielded bands at 2.5,  5.5, and 8.0 
kb for rat  and 11 and 2.1 kb for mouse. Hybridization of ABP cDNA 
with EcoRI-cleaved DNA  yielded bands at 18 and 5.5 kb for rat  and 
8.5 and 1.2 for mouse. The presence or absence of the specific bands 
representing rat ABP and HDC were determined for each cell hybrid 
and correlated with the  rat chromosomal content of each hybrid (31). 
Polymerase Chain Reaction-PCR using Taq DNA polymerase (33) 
was done with cDNA synthesized by random priming with hexanu- 
cleotides (34). Oligonucleotides for each PCR reaction are defined 
under "Results." Other oligonucleotides used for PCR of ABP cDNA 
(23) were oligo 1856, CCAGCTCAGCATGAGGA (17 residues 528- 
544), oligo 569-2, AGGGAGGCAAGTCTTAA (17 residues 1043- 
1027), and oligo 570, GTGGACAGCTGCTAACT (17 residues 18- 
34). Reaction conditions were 30 cycles; denaturation, 94 "C for 1 
min; annealing, 55 "C for 1 min; extension, 72 "C for 1 min. Products 
were analyzed by agarose gel electrophoresis and Southern blot hy- 
bridization. Hybridization conditions are described below. Extreme 
precautions were taken to minimize the chance of PCR product 
carryover in the PCR reactions (Perkin Elmer-Cetus Instruments). 
Positive controls were run  in  separate experiments and analyzed in 
another laboratory. 
Immunocytochemistry and Western Immunoblot-Polyacrylamide 
gel electrophoresis of proteins and western immunoblot analysis were 
done as described by Ausubel et al. (35). Fractionated  proteins were 
transferred to Immobilon-P membranes (Millipore) and immuno- 
reactive proteins were visualized with '251-labeled protein A and 
autoradiography (18). Immunocytochemical localization of ABP in 
fetal liver was done as previously reported, utilizing the "double PAP" 
method of immunostaining and counterstaining with toluidine blue 
(36-39). The rabbit ABP antiserum used in the immunological studies 
was either a previously characterized polyclonal antibody directed 
against the purified protein (36) or antibodies generated with peptides 
as immunogens. Based on the  rat ABP amino acid sequence predicted 
from the cDNA (23), the following peptides were synthesized that 
represented hydrophilic regions of the protein: Peptide A (653), 
DLTKISKPSSSFEFRTWDPE (residues 63-82); Peptide B (654), 
TVGFGPRLNDGRWHPVEL (residues 118-135). Peptides were 
synthesized by Dr. David Clapper (University of North Carolina) on 
a BioSearch model 9500 peptide synthesizer and each peptide was 
coupled to keyhole limpet hemocyanin with glutaraldehyde (39). The 
regime for production of rabbit antibodies has been previously de- 
scribed (39). 
Other Procedures-RNA was prepared by tissue extractions in 
guanidine thiocyanate and centrifugation in CsCl (40). DNA was 
prepared with proteinase K and sodium dodecyl sulfate (41). Restric- 
tion endonuclease digestions of DNA and fractionation by agarose 
gel electrophoresis were done by standard techniques (42). Southern 
blotting and hybridization using nick-translated [32P]DNA (43) was 
performed as described by Wahl  et ~ l .  (44). Blot hybridization analysis 
of RNA was done as described by Thomas (45) using 3ZP-labeled 
DNA (43). cDNA probes for rat testicular ABP (23) and fetal liver 
HDC (22) have been described. Brain identifier DNA (ID) elements 
(plasmids p2A120 and plB308) were from Dr. J. Gregor Sutcliff (46, 
47). DNA inserts were purified by electroelution from agarose or 
polyacrylamide gels for hybridization studies. For the blotting exper- 
iments the nucleic acids were transferred to BioTrans nylon mem- 
branes  (ICN) and hybridized with ABP or HDC  cDNA. Hybridization 
was in 5 X SSC (SSC = 0.15 M sodium chloride, 0.015 M sodium 
citrate), 50% formamide, 20 mM sodium phosphate, pH 6.5,  0.1  mg/ 
ml single-stranded salmon sperm DNA, 10%  dextran sulfate, 0.02% 
bovine serum albumin, 0.02%  Ficoll and 0.02% polyvinylpyrrolidone 
360 at 42 "C for 16 hr. After a final wash in 0.1 X SSC at 55 "C (DNA 
blot) or 65  "C (RNA blot), the hybridizing species were  visualized  by 
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autoradiography. Hybridizations of DNA and  RNA  blots  with '"P- 
labeled  oligonucleotides were done according to  Lathe (48). T o  ensure 
that  the oligonucleotides  were appropriate probes,  positive and neg- 
ative  DNAs were  hybridized as  controls,  except  for  the oligonucleotide 
representing an exon 7 deletion, for which no positive control was 
available. The sequence of the oligonucleotide  specific  for the  ABP 
exon 7 deletion was CCAAGACCAAGAGAGGACTC. Other oligo- 
nucleotides are described in "Results." 
For nucleotide  sequencing, restriction  endonuclease  fragments 
were  subcloned in bacteriophage  M13mp18 or M13mp19 (49). DNA 
sequences were determined by the dideoxy chain  termination  method 
(50, 51),  with RsS-labeled  deoxyadenosine 5'-[a-thio]triphosphate 
(Amersham Corp.). Oligonucleotides were synthesized based on  the 
nucleotide  sequences obtained  and used as primers  to walk  down the 
cDNAs  on  both  strands.  DNA homologous with testicular  ABP cDNA 
was  sequenced on a t  least  one  strand  and non-homologous  DNA  was 
sequenced on  both  strands.  Sequences were compared  with  each  other 
and  the Genetic  Sequence Data  Bank  (GenBank)  and  the  National 
Biomedical  Research Foundation  (NBRF)  Protein  Identification Re- 
source  with  Microgenie computer program (Beckman  Instruments). 
ABP RIA was done with the  kit supplied by the  National  Hormone 
and  Pituitary  Program  (27). Specific binding of ['Hldihydrotestoster- 
one  in  tissue  extracts was determined using the  dextran-coated  char- 
coal  method  (28).  The  preparation of extracts  and modifications of 
the assay for ABP have  been  previously  described (38). Briefly,  cell 
extracts were incubated  with 6 nM ['HIDHT  for 1 h a t  0 "C, charcoal 
treated for  2 min to remove unbound  DHT,  and  the radioactivity in 
the  supernatant fluid was determined by liquid scintillation  spectrom- 
etry. Specific binding was  calculated as previously  described  (28). 
Pregnant Sprague-Dawley rats were obtained from Charles River 
Labs  (Wilmington, MA). Rats were decapitated  and  the  embryos were 
excised and aged by length and skeletal formation. Tissues were 
excised and frozen in liquid  nitrogen. Protein  extracts of frozen tissues 
were prepared by disruption  in a  glass  homogenizer and processed as 
described  above for COS cells. Protein  concentrations of tissue  ex- 
tracts were determined after precipitation with 6% trichloroacetic 
acid, 0.15 mg/ml  sodium  deoxycholate. 
RESULTS 
Immunoreactive ABP and Dihydrotestosterone Binding in 
Fetal Liver-ABP radioimmunoassay of fetal rat liver extracts 
revealed an immunologically related protein. Soluble liver 
extracts from 16-, 18-, and 21-day embryos contained 11, 8.6, 
and 2.3 ng of ABP/mg of protein respectively, whereas the 
adult  rat caput epididymis and  testis contained 292 ng/mg 
and 25 ng/mg, respectively. The amount of ABP in the 
insoluble fraction was not determined. These declining ABP 
levels in liver coincide with the decreasing fetal  serum levels 
of immunoreactive ABP from 16  to 21 days after conception 
(21). A polyclonal antibody against purified ABP (36) was 
used to localize ABP  in  fetal liver by immunocytochemistry. 
The rabbit  antiserum reacted with hepatocytes in fetal liver, 
but because insufficient purified rat ABP was available for 
blocking experiments specificity could not be demonstrated. 
Therefore, based on the amino acid sequence of rat ABP we 
generated antibodies with synthetic peptides. One of these 
peptides  (peptide B) yielded an antibody  in  rabbit  serum with 
a high titer against ABP that reacted with the ABP-contain- 
ing cells and ducts of the  testis  and epididymis. Fig. lA shows 
immunostaining of the epididymal lumen and epithelial cells 
lining the lumen. These findings are in  agreement with the 
well  known pathway of ABP biogenesis where ABP is synthe- 
sized in the testis, secreted into  the seminiferous tubule lumen 
and transported to  the epididymis where it internalized by 
the epithelium (36). Pretreatment of the antibody with pep- 
tide B blocked staining of the epididymal and testicular struc- 
tures. Immunocytochemical localization of fetal liver ABP 
with this antibody demonstrated the presence of immuno- 
reactive protein in the hepatocytes of fetal liver at  15-day 
post-conception (Fig. 1, B and C). Asymmetric staining of the 
cytoplasm suggests that ABP is secreted from the hepatocytes 
in a polar fashion. Furthermore, pretreatment of the  anti- 
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FIG. 1. Immunocytochemical  localization  of ABP in  mouse 
ep id idymis   and   fe ta l  rat liver.  Tissues were fixed, sectioned, and 
the  antiserum (1:800 dilution)  against  ABP  peptide B  (Fig. 7, under- 
lined) was used with  the "double PAP"  method to detect immuno- 
reactive  ABP.  After the peroxidase  reaction the  tissues were counter- 
stained  with  toluidine blue. A, caput epididymis at low magnification 
(X 200). Immunoreactive  staining  is localized primarily  in  the lumen, 
with some  staining of the  epithelial cells that  line the lumen. This 
distribution of immunoreactive  material  is  consistent with the known 
location of ABP. i?, 15-day  fetal liver a t  low magnification (X  200). 
C, 15-day fetal liver a t  high magnification (X 2000). Antibody-de- 
pendent  staining  is  primarily located in  the cytoplasm of hepatocytes. 
D, 15-day  fetal liver (X  800). E, 16-day fetal liver (X  800). F, 17-day 
fetal liver (X 800). The intensity of hepatocyte staining decreased 
after 15 days of development. Preincubation of the antibody with 
excess peptide B (0.2 mg/ml) blocked formation of the signal in 
epididymis and  fetal liver at all ages. 
serum with peptide B blocked the staining in hepatocytes. 
The intensities of the specific hepatocyte staining were  lower 
at  16 and 17 days than  at 15 days post-conception, as were 
the percent of stained cells (Fig. 1, D-F),  consistent with the 
decline of RIA-determined ABP  after 16 days of development. 
Western blot analysis of the insoluble (14,000 x g pellet) 
fetal liver protein  detected  a signal corresponding in  size to 
that of the ABP subunit size (Mr = 43,000) (see below,  Fig. 
9). No M ,  43,000 signal was observed in the fetal liver soluble 
fraction or in either fraction of adult liver protein. The 
immunoreactive fetal liver protein ( M ,  = 43,000)  was present 
at  16-days post-conception, with much lower amounts at  15 
and 17 days of gestation. We do not know the subcellular 
location of the insoluble ABP. 
Specific ['HH]DHT binding was determined for protein ex- 
tracts of fetal liver at  various times of development. At each 
age (16-20 days post-conception) specific binding was de- 
tected at  a level approaching the lower limit of the assay 
(approximately 5 fmol of DHT/mg of protein). This level of 
specific binding corresponds to 0.4 ng of ABP/mg of protein, 
assuming one molecule of DHT bound/dimer of ABP. Under 
the conditions of assay (ligand occupied AR and 1 h incuba- 
tion at  0 " C )  little AR should be detected, however, it cannot 
be ruled out  that all or part of the activity is due to AR. 
Nevertheless, much less steroid-binding activity was detected 
than  the levels of ABP measured by RIA, suggesting that a 
large fraction of the immunoreactive ABP in the liver does 
not bind DHT.  Perhaps a non-steroid-binding form of ABP 
is not secreted, remaining in the liver (see discussion of 
alternative RNA processing below). 
146 Alternative Splicing of ABP  RN  Transcripts 
1.7 kb- 
I 2 3 4 5 6 7 8  M 
kb 
- 4.3 
- 2.3 - 2.0 
- 1.4 
FIG. 2. Tissue  distribution  of  ABP  mRNA. Poly(A)+  RNA (10 
pg)  from  various rat  tissues was analyzed by Northern  blot hybridi- 
zation with  "P-labeled ABP cDNA as probe. Lane I ,  adult  adrenal; 
lane 2, fetal  liver (16  days  after  conception); lune 3, adult liver; lune 
4, adult kidney; lane 5, 26-day testis; lane 6, adult  testis; lune 7, adult 
submandibular gland; lune 8, adult spleen. The RNA samples are 
flanked by "P-labeled single-stranded DNA  molecular  weight mark- 
ers (M); the sizes are  indicated  to  the  right of the  autoradiogram. 
The size of the major  hybridizing  species is  indicated at   the left. 
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FIG. 3. ABP  mRNA  dur ing   fe ta l  liver development. Preg- 
nant Sprague-Dawley rats were decapitated,  and  the  embryos were 
excised and aged by length  and  skeletal  formation.  Total RNA (20 
pg)  from liver a t  each age was analyzed by Northern  blot hybridiza- 
tion.  The size of the hybridizing mRNA species is  indicated at   the 
left. 
Localization of ABP mRNA in Fetal Liver-To determine 
if the immunoreactive ABP was synthesized in the fetal liver, 
we examined liver poly(A)+ RNA with testicular ABP cDNA 
as probe. Fig. 2 displays the autoradiogram of a Northern blot 
hybridization of liver RNA from the 16-day developing rat. 
The ABP cDNA probe hybridized with a 1.7-kb mRNA spe- 
cies in fetal liver poly(A)+ RNA (Fig. 2, lane Z), whereas 
testicular  poly(A)+ RNA contains  a much higher level of the 
1.7-kb ABP mRNA and also a  minor 2.3-kb species (lanes 5 
and 6 ) .  With  a much longer exposure of the autoradiogram a 
signal at  4.3 kb was seen in fetal liver, but  not  testis  (not 
shown, see Fig. 11 below). No bands of hybridization were 
detected in poly(A)+ RNA from rat ventral prostate (not 
shown),  adult liver, kidney, submandibular gland, or spleen, 
however, a faint signal at  1.7 kb observed in  adrenal poly(A)+ 
RNA  (Fig. 2, lane 1 ). The only other  adult  rat tissue where 
ABP mRNA has been detected is brain.' Fig. 3 shows the 
ontogeny of ABP mRNA expression in  fetal liver. The 1.7-kb 
hybridizing species was first detected at  14 days after concep- 
tion, with a decline in the proportion of ABP mRNA after 15 
days. In these  experiments  sex of the examined embryos was 
not determined, however, based on the serum levels of im- 
munoreactive ABP  in male and female embryos (21), which 
are identical, the fetal liver of both sexes likely produces ABP. 
* D. R. Joseph  and Y.-M. Wang,  unpublished  results. 
Cloning and Characterization of Fetal Liver ABP cDNA- 
We have previously described the testicular cDNA and gene 
structure of rat  ABP  and presented evidence that ABP  and 
SHBG are encoded by the same gene (13,23). Because human 
liver SHBG  and testicular ABP are regulated very differently 
we proposed that  alternate promoters and regulatory elements 
are utilized in  these  tissues (13). To compare testicular  and 
fetal liver ABP RNA transcripts in the  rat, we prepared 16- 
day fetal liver cDNA libraries  (oligo(dT)- or random-primed) 
and screened them for ABP cDNA. Four homologous fetal 
liver cDNAs were isolated and sequenced. The  structure of 
each clone compared with testicular ABP cDNA is shown 
diagrammatically in Fig. 4. Clone FLABPl was a partial 
cDNA identical  in sequence to testicular  ABP cDNA, except 
that it lacked 400 bp at  the 5'-end, whereas clone FLABP5 
(from a random-primed library) encoded nearly all of the 
testicular ABP protein, lacking only 9 nucleotide residues (3 
amino acid residues) at  the 3'-end of the amino acid coding 
region, Isolates FLABPl  and FLABP5 did contain the coding 
region in the correct reading frame for the proposed COOH- 
terminal  steroid-binding domain (52). 
Clones FLABP2 and FLABP-HDC represented alternately 
processed transcripts of the  ABP gene (Fig. 4). Clone FLABP2 
was identical to testicular ABP cDNA except exon 1 was 
replaced by an alternate sequence and exon 6 was totally 
missing. The lack of exon 6 causes a change in reading frame, 
resulting  in  a termination codon 18 bp into exon 7 (Fig. 5A). 
This altered mRNA encodes a 245-residue protein that does 
not contain the amino acids encoded by exons 7 and 8 of the 
ABP gene, which include the proposed steroid-binding do- 
main (52). Recently, Hammond et al. (12) and Gershagen et 
al. (53) have identified human  testicular ABP  transcripts with 
exon 7 deletions, which also result in removal of the steroid- 
binding domain. To investigate exon deletions  in rat testicular 
transcripts, we prepared oligonucleotides specific for exon 6 
(oligo FL3-X6, Fig. 5A, underlined) and exon 7 (see "Experi- 
mental Procedures") deletions. Hybridization with 20 unique 
testicular  ABP cDNA clones and 30 uncharacterized cDNA 
isolates determined that none contained exon 6 or 7 deletions. 
Thus, it appears that  the lack of the amino acids encoded by 
exons  6 or 7 do not contribute to  the  subunit s ze heterogeneity 
of testicular  ABP, which is primarily due to glycosylation (55, 
56). 
The sequence of clone FLABP2 also differed from the 
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FIG. 4. Diagrams  of fe ta l  liver cDNA  clones.  The open bar a t  
the top of the figure represents testicular ABP mRNA with the 
translation start (ATG) and termination (TAA) signals indicated. 
The sequences encoded by testicular exons 1-8 are marked below. 
The vertical dashed lines indicate  boundaries a t  exon junctions  in  the 
ABP gene. Open bars in  FLABPl,  FLABP2,  FLABP5,  and  FLABP- 
HDC  are  identical  to  testicular  ABP.  The solid line (del)  in FLABP2 
represents a deletion of exon 6. Stippled and hatched bars represent 
DNA that is  unrelated to testicular  ABP cDNA. The hatched area of 
FLABP-HDC  is 2.3 kb  and  identical  to  FLHDC.  FLHDC encodes all 
of rat HDC.  An  exon junction  in  FLHDC DNA is indicated by exon 
jum. ORF signifies an open  reading frame from the 5' terminus  to 
the  termination codon. Translation  initiation (ATG) and  termination 
(TAA, TGA, and TAG) codons are indicated. 
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FIG. 5. Nucleotide and  amino  acid  sequence of clone 
FLABPP. A, nucleotide sequence  and  deduced  amino  acid  sequence 
of clone  FLABP2  around  the  exon 5-7 junction.  The effect of the 
exon 6 deletion on  the deduced amino acid sequence of FLABP2  as 
compared with testis ABP ( A R P )  is shown. Nucleotide and amino 
acid residue numbers  are  displayed at  the  ends of each sequence. The 
testicular ABP amino acid sequence terminates at residue 403. A 
dashed line denotes  uninterrupted nucleotide sequence or amino  acid 
sequence. The complementary sequence of oligo FL3-X6 is under- 
lined. B, nucleotide sequence  and deduced amino  acid  sequence at   the 
5'-end of clone  FLABP2. The first 60 nucleotide residues contain  no 
Met or stop  codons  and  are  unique from testicular  ABP cDNA. The 
remaining sequence is  identical to  ABP  cDNA,  except for the  deletion 
of exon 6 (see A above). The deduced amino  acid  sequence of residues 
1-60 has no homology with  any  known  protein  in  the  data base. The 
complementary  sequence of oligo FL35P  is underlined. Oligo 3545, 
which  was  used  for PCR,  represented nucleotide residues 29-48. 
testicular ABP sequence in exon 1 (Fig. 5B). The unique 
sequence at   the  5'-end of clone  FLABP2  has  an  open  reading 
frame continuous with the testicular ABP cDNA reading 
frame  and  without a Met residue, therefore, we do  not know 
the site of translation initiation. These data support the 
hypothesis  that a unique  promoter  is  active  in  the liver. T o  
examine testicular transcripts for the alternate exon 1, an 
oligonucleotide specific for the 5'-region of FLABP2 (oligo 
FL35P. Fig. 5B, underlined) was hybridized with the 50 
testicular  ABP cDNA clones described  above. None  contained 
complementary sequences, indicating that this exon is not 
commonly  utilized in  the  testis. 
The presence of each of the cloned forms of fetal liver ABP 
mRNA was supported by PCR  analysis of the cDNA. cDNA 
was  prepared from  liver of developing rats (15-16 day)  and 
subjected to PCR  with  various  combinations of oligonucleo- 
tides. To  test for  the  presence of each  cDNA,  the following 
oligonucleotides  were  used (the  location  and  amplified region 
of each clone is  diagrammed in Fig. 6):  testicular  ABP  cDNA 
exon 1, oligos 570 and 569-2, theoretical 1025-bp product; 
fetal liver alternate  exon 1, oligos 3545 and 568, theoretical 
600-bp product; fetal liver exon 6 deletion, oligos 1856 and 
569-2, theoretical 516-bp DNA  with  testicular  cDNA  or 380 
bp  with  exon 6 deleted. Each set of oligonucleotides was  tested 
with the appropriate cloned cDNA and found to yield the 
predicted size fragment after amplification with PCR and 
each amplified  cDNA  hybridized with  ABP  cDNA  after  blot- 
ting. The oligonucleotides were then used to amplify fetal 
liver cDNA. In  each case the  reaction yielded the  predicted 
size product  as visualized  by ethidium  bromide  staining  (data 
not  shown). To confirm  the  nature of the  products,  the gel 
was  blotted  with a nylon membrane  and hybridized with  ABP 
cDNA. Fig. 6A demonstrates  that  each  stained  band  hybrid- 
ized with ABP cDNA. Oligos 570 and 569-2 yielded the 
predicted  1025-bp DNA, demonstrating  the  presence of the 
testicular  form of ABP  mRNA  in  fetal liver. With oligos 3545 
and 568, a 600-bp DNA was amplified, demonstrating the 
presence of the  alternate exon 1 sequence  in  fetal liver ABP 
mRNA. Oligos 1856 and 569-2 yielded 516- and 380-bp spe- 
cies, the expected DNAs if cDNAs  with  and  without  exon 6 
sequences were present. The nature of the high molecular 
weight  hybridizing  DNA in  each  lane  is  unknown.  No  hybrid- 
ization was  observed  when fetal liver  cDNA was  omitted from 
A. 
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FIG. 6. PCR of fetal  liver cDNA. The diagram describes the 
location of oligonucleotides  used  for PCR  and  the  theoretical  product 
size  from each clone. The open bar represents  testicular  ARP cDNA 
with  the  exon  sequences  indicated  (see Fig. 4). Oligonucleotides are 
indicated above or below their location on  each fetal  liver  cDNA and 
are  defined  in  the legends to Figs. 5 and 7 and  under  "Experimental 
Procedures." Oligos 570, 1856, and 3545 are based on  upper  strand 
sequence and oligos 569-2 and 568 are the complementary strand. 
The size of the  predicted  PCR  product is indicated between each  set 
of oligonucleotides. A, Southern blot analysis of PCH  products. 
Poly(A)+  RNA was prepared  from  the liver of fetal r a a  (15-16 days 
of gestation)  and cDNA  was synthesized  using 7 pg of poly(A)' RNA 
and  random  hexamers  as  primer. After cDNA  synthesis,  unreacted 
primers were removed by chromatography  on a Qiagen-tip 5 column 
(Qiagen Inc., Studio  City,  CA),  and  the cDNA  was precipitated with 
isopropyl  alcohol.  Aliquots (approximately 200 ng) of the  total cDNA 
product were subjected to PCR as described under "Experimental 
Procedures." Products were analyzed by  gel electrophoresis  and 
Southern  blot  hybridization with ABP cDNA as probe.  Autoradiog- 
raphy was  for 0.5 h with  Kodak XAR film and  intensifying screens. 
Lane I ,  oligos 570 and 569-2; lane 2, oligos 3545 and 568; lane 3 .  
oligos  1856 and 569-2. R and C, identification of the fusion transcript 
in  fetal liver RNA by PCR of the cDNA. Primers for amplification 
of the fusion transcript were oligos 1856 and h3-6 (Figs. 6 and 7. 
theoretical 572-bp product). Products were analyzed by agarose gel 
electrophoresis  and  blot hybridization  with an oligonucleotide specific 
for  the fusion junction of the  ARP  and  HDC  domains of FLARP- 
HDC DNA  (oligo  1210).  After transfer of the DNA from the gel to a 
nylon  membrane  the DNA was hybridized  with "'P-labeled oligo 1210 
(Fig. 7, legend) in 5 X SSC, 30% formamide at  25 "C for 16 h. The 
filter was  washed in 2 X SSC  and  the final stringent wash was in 0.2 
X SSC  at  25 'C for 20 min. R, amplification of fetal  liver  cDNA  with 
oligos 1856 and b3-6, hyhridization with oligo 1210. IAne 1.  16-day 
embryo; lane 2.17-day emhryo. C, control  samples,  hybridimtion with 
oligo 1210 as probe. Lane I ,  PCR of FLARP-HDC DNA with oligos 
1856 and B3-6; lane 2, PCR of FLARPS DNA  with oligos I856 and 
569-2 (gel electrophoresis  demonstrated  amplification of the  expected 
516-bp  DNA). The size of each major  hybridizing  species is indicated. 
- 2 3 m a  
the reaction. Amplification of fetal liver cDNA with oligos 
3545 and 569-2 yielded  a heterogeneous, high molecular 
weight, reaction  product  without  discrete  bands. 
The 5'-730 bp of clone  FLABP-HDC was  identical to  the 
testicular  ABP  cDNA  sequence  representing  exons 1-5 (13, 
23); however, beginning at   the end of exon 5 (15 bp 3' from 
EcoRI site),  the  remaining 2.3 kb was not homologous with 
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ABP cDNA  (Fig. 4). Fig. 7 shows the  total nucleotide sequence 
of clone FLABP-HDC (2975 bp) with the deduced amino acid 
sequence. The cDNA encodes a  protein of 98,000 molecular 
weight, with the  NHp-terminal region identical to testicular 
ABP (240 amino acid residues), including the signal peptide. 
The remaining amino acid sequence (643 residues) has no 
sequence identity with ABP. Comparison of the deduced 
amino acid  sequence of the 3‘-2.3 kb of FLABP/HDC with 
the National Biomedical Research Foundation Protein  Data 
Bank revealed extensive homology with the amino acid se- 
quence of aromatic L-amino acid decarboxylase (56).  Further 
cloning studies with expression of the full-length cDNA hom- 
ologue in COS cells, and genetic linkage analysis demon- 
strated  that  the L-amino acid decarboxylase-related domain 
encodes most of the cDNA for HDC (EC 4.1.1.22) (22,  HDC 
catalyzes the formation of histamine, a biogenic amine in- 
volved in numerous physiological processes, including neuro- 
transmittance, inflammation, vasomotor control, and gastric 
acid secretion). Amino acid residue 241 of FLABP-HDC cor- 
responds to  rat HDC residue 15, the remaining residues being 
identical to one of the allelic forms of HDC (22). This region 
of  homology includes the putative pyridoxal phosphate-bind- 
ing site of HDC (Lys-434, Fig. 7, underlined). In summary, 
FLABP-HDC cDNA encodes the signal peptide of ABP, likely 
the membrane receptor-binding domain of ABP (see “Discus- 
sion”) and all but 14 NHp-terminal amino acid residues of 
HDC. 
Identification of RNA Splice  Junction in Rat HDC Gem- 
In clone FLABP-HDC the end of the ABP nucleotide se- 
quence (residue 730) occurs at  an exon splice junction (donor) 
of the ABP gene (Fig. 8). To determine if the beginning of 
the HDC domain of FLABP-HDC (residue 731) also was at a 
splice junction, we began analysis of the HDC gene. Southern 
blot hybridization of rat DNA with the 3‘-2.3-kb EcoRI frag- 
ment of FLABP-HDC DNA as probe revealed hybridizing 
EcoRI fragments of 3.0, 10, and 17 kb (data  not shown). A 
phage Charon 4A genomic  DNA library (57) was constructed 
with partially EcoRI-digested rat DNA  (10-21 kb) and 
screened unamplified by in situ plaque hybridization with the 
HDC domain of clone FLABP-HDC (2.3-kb EcoRI fragment) 
and  an oligonucleotide probe specific for the sequence adja- 
cent to  the potential splice site (Fig. 7,  oligo  b3-7, complement 
of residues 761-777, ouerlined). Two positive recombinants 
were identified which contained 10- and 3-kb inserts (each 
with one stuffer fragment of Charon 4A DNA). Sequence 
analysis of the clones with oligo  b3-7 as primer revealed that 
the 10-kb DNA contained the identical sequence of FLABP- 
HDC upstream to residue 731, the beginning nucleotide of 
FIG. 7. Nucleotide sequence and 
deduced amino acid sequence of 
clone FLABP-HDC. The nucleotide 
and amino acid residue numbers are in- 
dicated at the right of each line. The 
regions that are identical with testicular 
ABP (nucleotide residues 1-730) and fe- 
tal liver  HDC (residues 731-end) are in- 
dicated above the nucleotide sequence. 
The difference in the number of amino 
acid residues (655 uersus 656 residues) 
in  this sequence and  the published HDC 
sequence is due to a mistake in the orig- 
inal manuscript (22, correction in  press). 
The HDC pyridoxal-binding site  (amino 
acid residues 490-496), the ABP signal 
peptide (amino acid residues 1-30) and 
the poly(A) addition signal (AATAAA, 
nucleotide residues 2937-2942) are 
underlined. Peptides (A and  B) used for 
antibody production are underlined. 
Oligonucleotides 1856 and  bl-3 are ouer- 
lined, as are the complementary se- 
quences of oligonucleotides b3-3, b3-6, 
and b3-7. Oligonucleotide  1210  was the 
complement of residues 721-740 and 
flanked the fusion point of the two do- 
mains. The complete sequence of oligo 
570 is described under “Experimental 
Procedures.” Other oligonucleotides are 
described under “Experimental Proce- 
dures.” Restriction endonuclease sites 
used for cloning in pCMV  DNA are  in- 
dicated with arrows. EcoRI sites and 
other residues from the linkers at the 
termini are not shown. Oligonucleotides 
1856 and b3-6 or b3-7 were used for 
PCR of the ABP-HDC fusion DNA and 
oligonucleotides bl-3  and b3-7 or  b3-6 
were  used in PCR of HDC  cDNA. 
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( i n t r o n  1) 
HDC qene- tccctctqcttgctqtcc&gGGAAAGAGATGGTGGATTACA 
I ( i n t r o n  5) 
ABP gene-  CAGAATTCACTCTCTCCAAGgfagactttttg~~agtCtCtt 
FIG. 8. Sequence of the  rat ABP-SHBG and HDC genes at 
intron-exon junctions adjacent to sequences where the cDNAs 
were joined in clone FLABP-HDC. cDNA sequence is uppercase 
were joined in FLABP-HDC DNA. The ABP-SHBG gene sequence 
and intron sequence is lowercase. A line denotes where the domains 
is from  Ref. 13. The HDC gene sequence was obtained from a 10-kb 
genomic DNA fragment with oligo b3-7 (See Fig. 7) as primer; the 
complement of oligo b3-7 is located 10 bases downstream from the 
last residue shown for the HDC gene. Consensus donor ( g t )  and 
acceptor (ag) splicing signals are underlined. 
the HDC domain (see Fig. 7). Juxtapositioned 5’ to  the first 
residue of the homology was a consensus acceptor splice 
sequence, TCCCTCTGCTTGCTGTCCAG (Fig. 8). Thus,  the 
ABP and HDC domains of FLABP-HDC cDNA appear to be 
joined at  donor and acceptor splice sites of the two genes.  No 
ID repetitive element (see “Discussion”) was observed by 
sequence analysis in  the intron within 500 bp of the splice 
junction. However, hybridization with cDNA probes repre- 
senting ID elements (46,47) revealed that  the 10-kb genomic 
DNA fragment did contain at least one ID element, with 
location(s) relative to HDC DNA unknown. Further  upstream 
at an unidentified location the 10-kb genomic  DNA contained 
the exon encoding the initiating methionine and  the putative 
transcription start site (unpublished results).’ This sequence 
was identified by direct sequence analysis of the 10-kb DNA 
and primer extension of poly(A) RNA with an HDC exon 1 
oligomer. 
Chromosomal  Localization of Rat HDC and  ABP Genes- 
To further evaluate the mechanism by which the FLABP- 
HDC transcript was formed, the chromosomal locations of 
the  rat ABP and HDC genes were obtained by analysis of cell 
hybrids. Rat-mouse cell hybrids generally discard some of the 
rat chromosomes, making it possible to use karyotyped hy- 
brids for mapping genes (31, 32). Rat  and mouse DNA was 
digested with a number of restriction endonucleases and  ana- 
lyzed by Southern blot hybridization with ABP and HDC 
cDNA as probes. Autoradiography revealed polymorphisms 
with ABP cDNA (EcoRI) and HDC cDNA (BarnHI) that 
could be used for mapping studies (see details under “Exper- 
imental Procedures”). Blot hybridization analysis of DNA 
from 13 mouse-rat hybrids, with ABP cDNA and HDC cDNA, 
revealed that eight hybrids contained the  rat ABP gene and 
seven contained the rat HDC gene (Table I). Of the 13 
hybrids, 7 were discordant for ABP and HDC DNA, clearly 
demonstrating that  the two genes are located on different 
chromosomes. Comparison of the  rat chromosomal content of 
the hybrid cells with the  rat ABP DNA content  demonstrated 
that  the presence or absence of ABP DNA was correlated 
with the presence or absence of chromosome 10, whereas, the 
presence of HDC  DNA appeared to be correlated with chro- 
mosome 3. With ABP cDNA no discordant hybrids were 
found for chromosome 10, whereas, at least 3 of 13 hybrids 
were discordant for the other chromosomes. The data also 
suggest that  the HDC gene is on chromosome 3, but because 
of the many low discordant numbers (2 to 3) of the other 
chromosomes, the assignment of the HDC  gene to  rat chro- 
mosome 3 should be considered as provisional. In support of 
the chromosomal locations of rat ABP-SHBG (Shbg) and 
HDC (Hdc) genes, the mouse  loci are located on chromosomes 
11 and 2, respectively (22, 58). Mouse chromosomes 11 and 2 
are partially homologous to  rat chromosomes 10 and 3, re- 
spectively (59). 
Biological Significance of the FLABP-HDC RNA Tran- 
script-Clone FLABP-HDC appeared to represent a fusion 
RNA transcript of two unique genes. Because of the unusual 
nature of the mRNA we designed experiments to test its 
biological significance. 
To determine if the fetal liver produced an ABP-like protein 
corresponding to  the size of the theoretical fusion protein, we 
analyzed fetal liver protein on immunoblots with ABP anti- 
sera. Fig. 9A demonstrates that  an immunoreactive protein 
the size of ABP (Mr  = 43,000)  was present in the insoluble 
protein (14,000 X g pellet) from liver extracts of developing 
rats at 15-17 days of gestation (lanes 3-5). It was also ob- 
served that a M ,  93,000 immunoreactive protein was present 
in the insoluble fetal liver protein (Figs. 9, A and B ,  short  and 
long exposure, lane 4 ) .  The estimated size of this immuno- 
reactive species is in close agreement with the predicted size 
of the fusion protein encoded by FLABP-HDC cDNA, minus 
the signal peptide (95,000 molecular weight). Like the M, 
43,000 protein species, the maximum immunoreactivity of the 
M ,  93,000 species was at 16 days. No immunoreactive protein 
migrating as M ,  = 93,000  was present in the soluble fetal liver 
protein or in either protein fraction from adult liver (not 
shown), brain  (not shown), testis (Fig.  9, lane 1 ), or epididymis 
(lune 2 ) .  As expected, immunoreactive ABP (Mr  = 43,000) 
was observed in the soluble fraction of testis  and epididymis 
(not shown). The major band of immunoreactivity migrating 
as  a M ,  60,000 protein corresponds to a major protein band 
on stained gels; this reactivity appears  not to be related to 
ABP. Immunoblot experiments with the antisera against ABP 
peptides A and B have proven not to be sensitive enough to 
detect either the M ,  43,000 or 93,000 species in fetal liver 
protein. These data demonstrate that a protein with some of 
the properties of the ABP-HDC fusion protein is transiently 
expressed in fetal liver. Whether  this immunoreactive protein 
represents the fusion protein remains to be determined. Ob- 
viously, parallel studies with HDC antiserum would have 
aided in the characterization of this protein. However, the 
requisite antibody against HDC is not available. 
The properties of the protein encoded by FLABP-HDC 
cDNA  were determined by expression of the cDNA  in COS 
cells. ABP cDNA, HDC cDNA, and FLABP-HDC cDNA 
were cloned into  the expression vector, pCMV,  yielding the 
recombinants pCMVABP6, pCMVHDC-18, pCMVFLABP- 
HDC, PCMV~FLABP-HDC, and pCMV5FLABP-HDCrev 
(construction details are described under “Experimental Pro- 
cedures”). COS 7 cells were transformed with the purified 
recombinant DNAs, and the cell extracts were assayed for 
ABP and HDC activity. pCMVABP yielded a high level of 
DHT binding activity in the medium, indicating that ABP is 
secreted, and pCMVHDC-18 yielded  high  HDC activity in the 
soluble and insoluble fraction (14,000 X g pellet) of the cell 
extract  (22). Surprisingly, over 90% of the HDC activity was 
located in the insoluble fraction; in a control study 95% of 
the fetal liver HDC activity was found in the soluble fraction. 
After sonication of the COS cell-insoluble fraction, all of the 
HDC activity remained in the 14,000 x g pellet, suggesting 
that most of the HDC in COS cells is in a membrane fraction 
or possibly stored in inclusion bodies as insoluble protein. 
Neither pCMVFLABP-HDC DNA nor pCMV5FLABP-HDC 
DNA yielded detectable cellular or secreted steroid binding 
activity. However, both FLABP-HDC DNA constructs 
yielded HDC enzymatic activity (1% of the level obtained 
with cells transformed with pCMVHDC-18) in the insoluble 
fraction of COS cell extracts, but not in the soluble cell 
fraction or medium. 
Fig. 10 displays autoradiograms of Western immunoblot 
analyses of transformed COS cells with ABP antiserum. 
Transformation with pCMVABP9  DNA  yielded immunoreac- 
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TABLE I 
Chromosome content of the mouse X rat hybrids and detection and assignment of the rat ABP and HDC genes 
The gene content of each  hybrid was determined by Southern blot  hybridization with ABP and HDC cDNA 
probes. The presence or  the absence of the  rat genes is  indicated by + or -, respectively; ND = not done. For the 
rat chromosomes, the symbols mean: + =chromosome  present in a t  least 60% of the metaphases; (+) =chromosome 
present in 30-50% of the metaphases; (-) = chromosome present  in 10-20% of the metaphases; - = chromosome 
absent. 
Rat genes Rat chromosomes 
ABP HDC X 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
Hybrids 
LB150-1 + + + - - + + - -  + -  + (-) + (+) + - - (+) (+) + (+) - 
LB161 + + + -  
LB210-1 
LB251 
- - +  " " _  - " -  " -  + +  - + - + -  - 
LB330TG3 - - - - - - + - - - - - - - 
LB330TG6 + - - - 
+ - - - - - - - - 
+ -   + -  + " -  
LB510-6 
+ -  + - - - - - - - - 
+ +  - + + + " + " "  + + +  + + + + -  - 
+ + + +  + + -  + + - ( - ) + +  + + + + +  (+) 
+ - +  + + ( - ) +  - (-) + - - + -  + + -  - - + -   + -  
LB600 + + + + + + + + ( + ) + - ( - ) + + + + + + + -  + +  - 




+ - " -  
ND - 
+ + -  + " "  + -  - 
+ - + - " -  + - -  + + - "  - - - + -  - 
LB810 + + + - + + + -  + + + -   + + + + +  + + + -  + (+I 
LB860 - + + - + + + - -  + -  + - + + + -  + + + + - ( + )  
LB150 N D + + ( - ) +  + + - - + - + + + + + - - + ( - I + +  (-1 
+ -  - 
LB210 ND - + - - - + - (-) - - - - - - + (+I (+) (+) (-1 + - (-) 
Discordant hybrids" 
LB1040TG5 + - - - - - + -  + (-) - - + + - - -  + + -  
ABP 6 6 4 6 5 7 3 5 7 7 0 5 6 6 8 7 7 6 7 4 7  
HDC 5 5 6 0 5 5  6 2 7 2 8 5 3 4 5 3 3 3 6 3 3  
Hybrids that contained chromosomes a t  10-2076 (-) were not included as discordant hybrids because they 
could appear  as + or - for the ABP and HDC genes. 
A B 
" " 




FIG. 9. Immunoblot analysis of rat  fetal  liver protein. Pro- 
teins from various tissues (14,000 X g pellet) were analyzed as de- 
scribed in the legend to Fig. 10. A, autoradiogram,  15-h exposure. B, 
55-h exposure. Lane I, testis; lune 2, epididymis; lane 3, 15-day  fetal 
liver; lune4,16-day fetal liver; lune 5,17-day  fetal liver. The  antiserum 
used for the immunoblots was directed against purified ABP (36). 
The long exposure of lane 5 is not shown because of signal  interference 
from the adjacent lane. 
tive protein (M, = 41,000 and 43,000) in  the medium (Fig. 
lOA, lane 4) ,  representing secreted ABP; a lower level of 
reactive protein was observed in the soluble cell extract 
(14,000 X g supernatant fluid) (lane 9) .  The size of the 
denatured  recombinant ABP is consistent  with the  subunit 
size of testicular  ABP, which is a homodimer composed of 
heterogeneous protomers due to differential glycosylation (54, 
55). No immunoreactive ABP was detected in cells or medium 
transformed with the  other recombinants; only nonspecific 
bands of reactivity were observed in all lanes. With a longer 
exposure of the autoradiogram, the lanes  containing  protein 
from cells transformed with pCMVFLABP-HDC and 
pCMV5FLABP-HDC DNA revealed immunoreactive bands 
migrating as M, 93,000 proteins (Fig. lOB, lanes 7 and 8). 
This immunoreactive band was not observed in the protein 
of cells transformed with pCMVABP9, pCMVHDC18, or 
pCMV5FLABP-HDCrev (lanes 6, 9, and IO). Furthermore, 
this protein species was not found in the medium of any 
transformed cells, including cells transformed with the two 
FLABP-HDC DNA constructs.  On the contrary, like the COS 
cell HDC, large amounts of the 93,000 molecular weight 
protein were found in the insoluble fraction of COS cells 
(14,000 X g pellet)  transformed with the FLABP-HDC DNA 
recombinants (Fig. lOC, lanes 2 and 3). In addition, smaller 
bands of reactivity were present that likely resulted from 
proteolysis. Our conclusion that  the 93,000 molecular weight 
species is encoded by FLABP-HDC DNA is supported by 
immunoblot analysis  with the ABP  antiserum raised against 
peptide B (see above). As with the first  antibody,  a specific 
band of reactivity (Mr = 93,000)  was observed in the 14,000 
x g pellet fraction from cells transformed with the FLABP- 
HDC DNA recombinants (Fig. 1OD, lanes 2 and 3). Thus,  the 
immunoreactive protein encoded by FLABP-HDC DNA is 
not secreted by COS cells even though translation should 
initiate with the  ABP signal peptide. Perhaps  the HDC do- 
main contains a sequence that targets the protein from the 
rough endoplasmic reticulum to another cellular compart- 
ment. The cellular location of HDC is not known, although a 
fraction of HDC is thought  to be membranous in the adult 
brain. 
Northern hybridization was used to determine if a fetal 
liver RNA species may contain both the HDC and ABP 
domains. The 2.3-kb 3'-EcoRI fragment (HDC) of clone 
FLABP-HDC and  ABP cDNA were used to probe a  Northern 
blot (Fig. 11). This 2.3-kb fragment  contains HDC cDNA and 
15 bp of ABP cDNA but does not hybridize with ABP mRNA 
or cDNA. After hybridization with ABP cDNA the blot was 
stripped of radioactivity and autoradiographed to confirm that 
stripping was complete. The RNA blot was then hybridized 
with HDC cDNA (Fig. 11). The HDC DNA probe hybridized 
with  a major 3.2-kb mRNA species and a minor 4.4-kb species 
in fetal liver poly(A)+ RNA (lane 1) .  No hybridization was 
seen with poly(A) RNA from adult rat liver or testis (lanes 2 
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FIG. 10. Western immunoblot analysis of pCMV transfor- 
mation products. Cell extracts (soluble and insoluble fractions) and 
concentrated medium (0.1 mg  of protein/lane) were fractionated by 
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (8% acryl- 
amide)  transferred to Immobilon-P  membranes and  treated with  ABP 
polyclonal antibody against purified ABP (A-C) or polyclonal anti- 
body to peptide B (D). Immunoreactive proteins were identified with 
9-labeled protein  A and autoradiography. A ,  medium and soluble 
cell extracts, 20-h exposure to Kodak XAR film with intensifying 
screen. Lanes 1-5, concentrated medium. Lanes 6-10, soluble cell 
extracts. Lanes I and 6, COS cells transformed  with  pCMVHDC-18 
DNA; lunes 2 and 7, pCMVFLABP-HDC DNA; lunes 3 and 8, 
pCMV5FLABP-HDC DNA; lunes 4 and 9, pCMVABP6 DNA; lunes 
5 and 10, pCMVFLABP-HDCrev DNA. B, autoradiogram from A ,  
exposed for 5 days. C, insoluble membrane fraction, 2-h exposure. 
Lanes are numbered as in A .  D, insoluble fraction  with  antibody to 
peptide B, 2-h exposure. Lanes are numbered as in A. Molecular 
weights of reactive proteins were determined by comparison of mi- 
gration distances with known standards (High Molecular Weight 
Rainbow Markers, Amersham Corp.). The M, of specific immuno- 
reactive bands  is  indicated on  the flanks. Bands in A ,  B, C, and D 
that occur in all lanes  are  not specific for ABP immunoreactivity. All 
pCMV constructs  are in the correct orientation for expression except 
pCMVABP-HDCrev. A large fraction of the immunoreactive ABP 
from pCMVABP9 transformed cells was contained in  the 14,000 X g 
pellet, with only  a trace in the soluble fraction. The  nature of the 
immunoreactive band a t  37 kDa in the insoluble fraction  is  unknown 
( C ,  [one 4 ) ,  but  it likely represents unglycosylated ABP (55). This 37 
kDa species is  not observed in the secreted  fraction ( A ,  lune 4 ) .  
and 3). As described above, ABP cDNA hybridized with fetal 
liver mRNA species of  1.7 and 4.4 kb (Fig. 11, lune I). Thus, 
ABP cDNA and HDC cDNA hybridize to a 4.4-kb fetal liver 
mRNA, which  may represent the ABP-HDC fusion transcript. 
However, hybridization of the two cDNAs to two unique 4.4- 
kb RNAs remains  a possibility. 
PCR was also utilized to assay for fusion transcripts  anal- 
ogous to FLABP-HDC DNA in fetal liver RNA. cDNA was 
synthesized from fetal liver poly(A) RNA (16 and 17 days 
after conception) and subjected to PCR (30 cycles) with 
oligonucleotides flanking the fusion point of the two domains 
(see Figs. 6 and 7). After PCR of the single-stranded cDNA 
with oligonucleotides 1856 and b3-6, gel electrophoresis of 
the products revealed no stained DNA of the predicted size, 
whereas PCR of FLABP-HDC cDNA yielded the predicted 
572-bp DNA. Although no 572-bp DNA was detected by 
staining  after PCR, Southern blot hybridization analysis of 
the products from 17-day DNA with ABP cDNA did yield a 
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FIG. 11. Northern blot analysis of fetal liver RNA with ABP 
and HDC cDNA probes. Poly(A) RNA was purified from rat tissues, 
fractionated by electrophoresis  on agarose gels, transferred to nylon 
membranes, and hybridized with testicular ABP cDNA (ABP)  or  the 
3'-2.3-kb EcoRI fragment of clone FLABP-HDC (HDC). 10 pg of 
poly(A)+  RNA/lane. Lane I ,  16-day fetal rat liver; lune 2, adult male 
liver; lune 3, testis  (adult); lane 4, "P-labeled single-stranded DNA 
size markers. The sizes (kb) of the markers are shown between the 
autoradiograms and  the  estimated size of each hybridizing band  is 
indicated  outside  each  autoradiogram. 
as  the major PCR  product of FLABP-HDC cDNA  (572 bp). 
No band of hybridization was observed with cDNA from 16- 
day embryos or in  the control  PCR reaction with no added 
DNA. This hybridizing DNA species was identified to be the 
product of the fusion cDNA by hybridization with an oligo- 
nucleotide specific for the ABP-HDC DNA fusion point. 
Oligonucleotide 1210 (20 residues) consisted of 10 nucleotide 
residues complementary to  ABP cDNA and 10 residues com- 
plementary to HDC cDNA. (The sequence and location of 
this sequence is described in the legend to Fig.  7.) This 
oligonucleotide hybridized to FLABP-HDC cDNA but did not 
hybridize to  ABP  or HDC cDNA under  our reaction condi- 
tions. Fig. 6  demonstrates that  this oligonucleotide hybridized 
to  the 572-bp PCR  product of FLABP-HDC cDNA  (Fig. 6C, 
lane I ) and  to a similar size DNA species in the PCR  products 
of 17-day fetal liver cDNA (Fig. 6B, lune 2) and a very faint 
signal from 16-day liver cDNA (lane I ), but not from products 
amplified from ABP cDNA (Fig. 6C, lune 2). In addition, in 
control  PCR  reactions with oligonucleotides B3-6 and 1856 
without added cDNA no hybridization signal at  572 bp was 
observed. Even after 60 cycles of amplification in the absence 
of cDNA no signal was present. Positive reactions of the 
fusion product were obtained with cDNAs from two different 
RNA preparations derived from liver of 17-day embryos. 
DISCUSSION 
Our  studies have demonstrated that  the ABP gene is ex- 
pressed transiently during fetal rat liver development. Im- 
munoreactive protein was primarily localized in hepatocytes 
of fetal liver, where it is likely synthesized. Most of the ABP 
synthesized in  fetal liver appears to be secreted into  the blood 
(20, 21), however, our  studies found a fraction of immuno- 
reactive protein  in an insoluble cellular compartment. Anal- 
yses of the fetal liver steroid binding activity and cDNA 
encoding properties of ABP mRNA indicate that fetal liver 
ABP is capable of specific DHT binding. 
During the time of ABP gene expression in the fetal male 
rat (15-17 days of gestation), the level of testosterone is high; 
after 19  days of gestation the concentration declines until  3 
weeks of life (60). At 15-17 days of gestation high concentra- 
tions of testosterone are required in the male fetus for differ- 
entiation of the Wolffian duct into  the pididymis and seminal 
vesicle (61,62). Also, high androgen levels are required during 
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the last week of gestation and immediately after birth for 
normal development of the male brain (63). During this time 
of development (birth to 6 days of age) ABP gene expression 
initiates in the brain.' It is our hypothesis that plasma and 
brain ABP act  as  a  carrier of androgens to facilitate these 
developmental processes. Interaction of testosterone-bound 
ABP with cell surface receptors could target  testosterone to 
specific sites, where androgen is required for differentiation 
and imprinting. Although it has been assumed that steroids 
can readily enter cells by diffusion, evidence is accumulating 
for the role of carrier proteins  in cellular uptake of steroids 
via specific surface receptors (3). Since the most evolution- 
arily conserved ABP-SHBG amino acid sequence between 
species is encoded by exon 3 this sequence could be the 
receptor-binding domain (the steroid-binding domain is at 
least partly located near the COOH terminus; encoded by 
exons 7  and 8). In  support of this idea, Rosner and co-workers3 
have demonstrated that a peptide encoded by human  ABP- 
SHBG exon 3 binds with high affinity to  the human ABP- 
SHBG membrane receptor. 
Clone FLABP2 represented an alternatively spliced tran- 
script of the ABP gene, with a unique exon 1. We have not 
yet localized this sequence in the gene, but it originates from 
a promoter distinct from the putative testicular promoter, 
greater than 4.0 kb upstream from the identified testicular 
start site.' In analogy, the utilization of tissue-specific pro- 
moter-regulatory regions has been described for a number of 
genes  (64, 65). We  have recently identified brain ABP tran- 
scripts that contain  another unique exon 1, with a  portion of 
the sequence located 4.0 kb upstream of the testicular start 
site; yet another unlocalized exon exists further upstream. 
These  data indicate that  the ABP gene is complex, with at 
least two, possibly 3, promoters. Hammond et al. (12) and 
Gershagen et al. (53) have characterized human testicular 
ABP cDNAs, which contain  alternate  first exons, encoding 
amino acid residues unrelated to human liver SHBG or any 
of the known rat  testis,  fetal liver, or brain ABP amino acid 
sequences. 
Clone  FLABPB also differed from testicular cDNA  by the 
absence of exon 6, resulting in a deletion of the proposed 
steroid-binding domain from the encoded protein. Likewise, 
two other laboratories (12, 53) have identified a  human  tes- 
ticular cDNA lacking exon  7,  which also results in removal of 
the putative steroid-binding domain. Since the  alternate hu- 
man and rat transcripts contain testicular exons 2-5, they 
both would appear to encode proteins with a similar function. 
If the encoded proteins  retain the receptor-binding capacity 
(see discussion of receptor-binding domain in exon 3 above) 
without steroid binding they could act  as  natural  antagonists 
to regulate ABP action. Such an antagonist  has been described 
for the thyroid hormone receptor, where alternative RNA 
splicing generates a  protein with a functional DNA-binding 
domain, but  a non-functional T3-binding domain, yielding a 
protein with opposing biological activity (66).  Likewise, other 
alternatively processed RNAs have been shown to encode 
proteins with different functions (67, 68). The concept that 
ABP and  SHBG may  have direct regulatory effects at  the cell 
surface has recently been proposed by Rosner and co-workers 
(3, 69-71). They have presented evidence that human  SHBG 
acts  as  a hormone via the receptor, increasing intracellular 
CAMP levels (3,70). More recently, they have shown that  the 
interaction of SHBG with the cell surface receptor is modu- 
lated by bound androgen and have developed a model for 
ABP-SHBG action (71). 
cDNA Clone FLABP-HDC encoded regions of ABP and 
W. Rosner, personal communication. 
HDC domains, which  were joined at donor and acceptor RNA 
splice junctions of the two  genes. Since the ABP and HDC 
genes are located on different rat chromosomes, this tran- 
script was apparently formed by a  trans splicing process. It is 
highly unlikely that  this cDNA  was generated by a cloning 
artifact. The following findings support the possibility that a 
representative transcript is expressed in fetal liver. 1) The 
ABP and HDC genes are  transcriptionally active during  this 
developmental period (from 15 days post-conception until 
birth  the fetal liver contains extremely high  levels of HDC 
mRNA).' 2) The fetal liver hepatocyte is the primary location 
of immunoreactive ABP and HDC (72) and is likely the  site 
of HDC and ABP gene transcription.  3) Hybridization studies 
identified a 4.4-kb poly(A)+ RNA(s) that hybridized with ABP 
and HDC cDNA. 4) PCR experiments indicate that a fusion 
transcript analogous to clone FLABP-HDC is synthesized in 
fetal liver. 5) An immunoreactive protein  consistent with the 
size of the protein encoded by the fusion DNA  was identified 
in fetal liver. 6)  The hybridization-reactive 4.4-kb  RNA and 
the immunoreactive M, 93,000 protein were  localized only in 
fetal liver and  not  adult liver, testis, epididymis, or brain. Our 
data support  a trans-splicing mechanism for formation of the 
fusion transcript, however, a mechanism involving recombi- 
nation at  the DNA  level cannot be ruled out. In vivo trans 
splicing of RNA transcripts  has  not been reported in verte- 
brates.  Trans splicing of nuclear pre-mRNAs does occur in 
trypanosomes and nematodes, but  it is limited to the splicing 
of a signal sequence to  the 5'-end of the mRNA  (73-75).  Also, 
trans splicing appears  to be  involved in  the formation of some 
Chlamydomonas chloroplast RNAs, a process that affects the 
region encoding protein  (76). 
ID elements may  have been involved in the formation of 
the alternatively processed ABP  transcripts. Rat ID elements 
are middle repetitive DNA sequences, containing RNA polym- 
erase I11 promoters (46, 47), that are expressed in many 
tissues, with one of the poly(A)+ transcripts (BC1, 160 resi- 
dues) specifically expressed in brain  and  another RNA  species 
(T3, 75 residues) in testis (77). It has been proposed that 
these elements act  to identify specific genes to be expressed 
in brain  and possibly other  tissues (46, 47). Also, it  has been 
postulated that ID RNAs are associated with the processing 
of RNA polymerase I1 transcripts,  but  strong evidence sup- 
porting this hypothesis is lacking. Three of these elements 
are associated with the  rat ABP gene, one in opposite orien- 
tation (13). The reversed element is in the 3'-flanking DNA, 
near the poly(A) addition site, and the other two elements 
(same orientation)  are in the intron between exons 5  and 6, 
adjacent to  the region of the alternative splicing phenomena. 
Interestingly, the ID elements, in opposite orientation, flank 
the region of the ABP-SHBG gene missing in the fusion 
cDNA (exons 6-8). These findings suggest that  the expressed 
RNAs of these elements may  be  involved in  alternative splic- 
ing of ABP transcripts. The presence of ID transcripts in 
tissues expressing ABP RNA transcripts would inhibit  intra- 
molecular hybridization and could presumably affect splicing. 
The recent observation that the human ABP-SHBG gene 
contains an ALU repetitive element in an intron adjacent to 
the  alternate splice site (12) supports the role of repetitive 
elements in RNA splicing of the ABP-SHBG gene. Since at 
least one of these elements is associated with the HDC  gene, 
complementary ID elements could also have been  involved in 
the formation of the FLABP-HDC transcript. In analogy, 
trans splicing of mRNA precursors has been demonstrated to 
occur in nuclear extracts with two RNA transcripts con- 
structed to contain complementary sequences in their  introns 
(78, 79). Base pairing between RNAs was thought to bring 
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the transcripts  together for  intermolecular  splicing.  Based on 
these in uitro studies, Solnick (78) supposed that the most 
likely candidates for RNAs that undergo trans splicing are 
those that contain  repetitive elements in  their introns. 
A  surprising  observation  was the localization  of most of the 
immunoreactive  fetal  liver ABP to the insoluble  fraction. As 
expected, immunoreactive ABP from testis and epididymis 
was  in the soluble  fraction.  At this time we  do not know the 
subcellular  localization  of the immunoreactive M ,  43,000 and 
93,000 proteins,  however, they would  appear to be  membrane- 
bound  or  stored in insoluble  granules. If the M, 93,000 protein 
represents the ABP-HDC fusion  protein, it should be targeted 
to the rough endoplasmic reticulum (i.e. the cDNA encodes 
the ABP  signal peptide). Furthermore,  interaction  of the ABP 
receptor-binding region with the protein trafficking system 
could direct the protein to a subcellular compartment con- 
taining the ABP receptor (e.g. vesicles). Even though the 
protein  is  not  secreted from COS cells the possibility exists 
that it is secreted from liver. Secreted or not secreted, the 
enzymatically  active HDC domain  of the fusion  protein  could 
be  directed to a site, not  accessible by  normal  HDC. 
The results of this study  strongly support the hypothesis 
that trans splicing  of  ABP  and  HDC  RNA  transcripts  occurs 
in fetal rat liver. Whether this phenomenon has biological 
significance,  creating  a  functional  fusion  protein,  remains to 
be  determined. 
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